InfuSystem Holdings, Inc.
ASE: INFULive Quote
📈 ZcoreAI Score
Our AI model analyzes InfuSystem Holdings, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get INFU Z-Score →About InfuSystem Holdings, Inc.
Healthcare
Medical Devices
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
📊 Fundamental Analysis
InfuSystem Holdings, Inc. demonstrates a profit margin of 4.6%, which is below the sector average, suggesting competitive pressure.
The company recently reported 7.0% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 11.5%, which suggests room for improvement in capital utilization.
At a current price of $9.38, INFU currently sits at the 74th percentile of its 52-week range (Range: $4.66 - $11.04).
💰 Valuation Insight
INFU is valued broadly in line with the sector at a PE of 30.26. Analysts anticipate some earnings pressure, with a higher forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$190.75M
Trailing P/E
30.26
Forward P/E
32.34
Beta (5Y)
1.55
52W High
$11.04
52W Low
$4.66
Avg Volume
126K
Day High
Day Low